Document is current
Any future updates will be listed below
-
Authors
Wall, Jeffrey D. http://orcid.org/0000-0001-5066-1235
Sathirapongsasuti, J. Fah
Gupta, Ravi
Rasheed, Asif
Venkatesan, Radha http://orcid.org/0000-0002-4281-0250
Belsare, Saurabh http://orcid.org/0000-0002-8148-1867
Menon, Ramesh
Phalke, Sameer
Mittal, Anuradha
Fang, John http://orcid.org/0000-0003-2372-0839
Tanneeru, Deepak
Deshmukh, Manjari
Bassi, Akshi http://orcid.org/0000-0002-4443-1430
Robinson, Jacqueline http://orcid.org/0000-0002-5556-815X
Chaudhary, Ruchi
Murugan, Sakthivel
ul-Asar, Zameer
Saleem, Imran
Ishtiaq, Unzila
Fatima, Areej
Sheikh, Saqib Shafi
Hameed, Shahid
Ishaq, Mohammad
Rasheed, Syed Zahed
Memon, Fazal-ur-Rehman
Jalal, Anjum
Abbas, Shahid
Frossard, Philippe
Fuchsberger, Christian
Forer, Lukas http://orcid.org/0000-0003-2139-7329
Schoenherr, Sebastian
Bei, Qixin
Bhangale, Tushar
Tom, Jennifer
Gadde, Santosh Gopi Krishna
B V, Priya
Naik, Naveen Kumar
Wang, Minxian http://orcid.org/0000-0002-3753-508X
Kwok, Pui-Yan http://orcid.org/0000-0002-5087-3059
Khera, Amit V. http://orcid.org/0000-0001-6535-5839
Lakshmi, B. R.
Butterworth, Adam S. http://orcid.org/0000-0002-6915-9015
Chowdhury, Rajiv
Danesh, John
di Angelantonio, Emanuele
Naheed, Aliya
Goyal, Vinay
Kandadai, Rukmini M.
Kumar, Hrishikesh
Borgohain, Rupam
Mukherjee, Adreesh
Wadia, Pettarusp M.
Yadav, Ravi
Desai, Soaham http://orcid.org/0000-0003-0378-1888
Kumar, Niraj http://orcid.org/0000-0002-5863-2532
Biswas, Atanu
Pal, Pramod Kumar
Muthane, Uday B.
Das, Shymal K.
Ramprasad, Vedam L.
Kukkle, Prashanth L. http://orcid.org/0000-0002-4610-947X
Seshagiri, Somasekar
Kathiresan, Sekar
Ghosh, Arkasubhra
Mohan, V. http://orcid.org/0000-0001-5038-6210
Saleheen, Danish http://orcid.org/0000-0001-6193-020X
Stawiski, Eric W. http://orcid.org/0000-0002-9387-6719
Peterson, Andrew S.
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 15 May 2023
First Online: 8 June 2023
Competing interests
: J.D.W. has worked as a consultant for Genentech, MedGenome, and Maze Therapeutics, and has received research funding from Genentech. J.F.S. is a former employee and shareholder of 23andMe. A.V.K. is an employee of Verve Therapeutics; has served as a scientific advisor for Sanofi, Amgen, Maze Therapeutics, Novartis, Silence Therapeutics, Veritas International, Color Health, and Third Rock Ventures; holds equity in Verve Therapeutics, Marea Therapeutics, Color Health and Foresite Labs; and received a sponsored research agreement from IBM Research. The remaining authors declare no competing interests.
